BCX 71H E6327 Infineon Technologies, BCX 71H E6327 Datasheet - Page 11
![no-image](/images/manufacturer_photos/0/3/327/infineon_technologies_sml.jpg)
BCX 71H E6327
Manufacturer Part Number
BCX 71H E6327
Description
TRANSISTOR PNP AF 45V SOT-23
Manufacturer
Infineon Technologies
Datasheet
1.BCX_71K_E6327.pdf
(11 pages)
Specifications of BCX 71H E6327
Transistor Type
PNP
Current - Collector (ic) (max)
100mA
Voltage - Collector Emitter Breakdown (max)
45V
Vce Saturation (max) @ Ib, Ic
550mV @ 1.25mA, 50mA
Dc Current Gain (hfe) (min) @ Ic, Vce
180 @ 2mA, 5V
Power - Max
330mW
Frequency - Transition
250MHz
Mounting Type
Surface Mount
Package / Case
SOT-23-3, TO-236-3, Micro3™, SSD3, SST3
Lead Free Status / RoHS Status
Lead free / RoHS Compliant
Current - Collector Cutoff (max)
-
Other names
BCX71HE6327XT
SP000010631
SP000010631
BCW61..., BCX71...
Edition 2006-02-01
Published by
Infineon Technologies AG
81726 München, Germany
© Infineon Technologies AG 2007.
All Rights Reserved.
Attention please!
The information given in this dokument shall in no event be regarded as a guarantee
of conditions or characteristics (“Beschaffenheitsgarantie”). With respect to any
examples or hints given herein, any typical values stated herein and/or any information
regarding the application of the device, Infineon Technologies hereby disclaims any
and all warranties and liabilities of any kind, including without limitation warranties of
non-infringement of intellectual property rights of any third party.
Information
For further information on technology, delivery terms and conditions and prices
please contact your nearest Infineon Technologies Office ( www.infineon.com).
Warnings
Due to technical requirements components may contain dangerous substances.
For information on the types in question please contact your nearest
Infineon Technologies Office.
Infineon Technologies Components may only be used in life-support devices or
systems with the express written approval of Infineon Technologies, if a failure of
such components can reasonably be expected to cause the failure of that
life-support device or system, or to affect the safety or effectiveness of that
device or system.
Life support devices or systems are intended to be implanted in the human body,
or to support and/or maintain and sustain and/or protect human life. If they fail,
it is reasonable to assume that the health of the user or other persons
may be endangered.
2007-10-18
11